Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction.
Jorge A. Marrero
Consultant or Advisory Role - Bayer/Onyx
Honoraria - Bayer
Research Funding - Bayer
Riccardo Lencioni
Honoraria - Bayer Schering Pharma
Research Funding - Bayer
Sheng-Long Ye
No relevant relationships to disclose
Masatoshi Kudo
No relevant relationships to disclose
Jean-Pierre Bronowicki
Honoraria - Bayer
Research Funding - Bayer
Xiao-Ping Chen
Honoraria - Bayer
Lucy Dagher
Research Funding - Bayer
Junji Furuse
Honoraria - Bayer
Research Funding - Bayer
Jean-Francois Geschwind
Employment or Leadership Position - John Hopkins Hospital
Consultant or Advisory Role - Bayer; Biocompatibles; Delcath Systems ; Jennerex Biotherapeutics; Nordion; Philips Healthcare; Prescience Labs
Honoraria - Bayer; Biocompatibles; Delcath Systems ; Guerbet; Jennerex Biotherapeutics; Nordion; Prescience Labs
Research Funding - Bayer; Biocompatibles; Department of Defense; Guerbet; NCI-ECOG; NIH-RO1; Nordion; Philips Healthcare
Laura LadrĂ³n de Guevara
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Christos Papandreou
Honoraria - Bayer
Research Funding - Bayer
Arun J. Sanyal
Consultant or Advisory Role - Gore; Merck; Norgine; Roche; Salix Pharmaceuticals
Research Funding - Bayer/Onyx; Exalenz Bioscience; Genentech; Gilead Sciences; Intercept Pharmaceuticals; Salix Pharmaceuticals
Other Remuneration - UpToDate
Tadatoshi Takayama
Honoraria - Bayer
Research Funding - Bayer
Seung Kew Yoon
No relevant relationships to disclose
Keiko Nakajima
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Alan Paul Venook
Consultant or Advisory Role - Bayer/Onyx (U)
Research Funding - Bayer/Onyx